Skip to main content
Chuang-Kuo Wu, MD, Neurology, Providence, RI

Chuang-KuoWuMD

Neurology Providence, RI

Spinal Disorder, Vascular Neurology

Associate Professor, Neurology, Texas Tech University Health Science

Are you Dr. Wu?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    593 Eddy St
    Providence, RI 02903
    Phone+1 401-444-6788
    Fax+1 401-444-6912

Summary

  • Dr. Chuang-Kuo Wu, MD is a board certified neurologist in Providence, Rhode Island. He is currently licensed to practice medicine in Rhode Island, Texas, and Illinois. He is an Associate Professor at Texas Tech University Health Science.

Education & Training

  • Boston University School of Medicine
    Boston University School of MedicineClass of 1988

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2001 - 2027
  • RI State Medical License
    RI State Medical License 2003 - 2026
  • TX State Medical License
    TX State Medical License 2010 - 2026
  • MA State Medical License
    MA State Medical License 1999 - 2012
  • IL State Medical License
    IL State Medical License 2007 - 2011
  • Neurology
    American Board of Psychiatry and Neurology Neurology
  • Vascular Neurology
    American Board of Psychiatry and Neurology Vascular Neurology

Publications & Presentations

PubMed

Press Mentions

  • Two R.I. Hospitals Involved in Global Trial That Found Effective Drug Against Early Alzheimer’s
    Two R.I. Hospitals Involved in Global Trial That Found Effective Drug Against Early Alzheimer’sOctober 9th, 2022
  • Associations of Regional Brain Structural Differences with Aging, Modifiable Risk Factors for Dementia, and Cognitive Performance
    Associations of Regional Brain Structural Differences with Aging, Modifiable Risk Factors for Dementia, and Cognitive PerformanceDecember 2nd, 2019
  • FDA Fully Approves Alzheimer's Drug Leqembi
    FDA Fully Approves Alzheimer's Drug LeqembiJuly 14th, 2023